Lord, Abbett & Co
ABMD

Lord, Abbett & Co’s Abiomed Inc ABMD Stock Holding History

Lord, Abbett & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-27,286
Closed -$3.96M – 705
2020
Q1 		$3.96M Sell
27,286
-3,754
-12% -$623K 0.02% 563
2019
Q4 		$5.29M Sell
31,040
-2,378
-7% -$441K 0.02% 593
2019
Q3 		$5.95M Buy
33,418
+5,549
+20% +$1.2M 0.02% 615
2019
Q2 		$7.26M Buy
27,869
+11,317
+68% +$3M 0.02% 614
2019
Q1 		$4.73M Buy
16,552
+412
+3% +$137K 0.02% 654
2018
Q4 		$5.25M Buy
16,140
+1,581
+11% +$549K 0.02% 644
2018
Q3 		$6.55M Sell
14,559
-7,250
-33% -$2.86M 0.02% 693
2018
Q2 		$8.92M Sell
21,809
-27,592
-56% -$10M 0.03% 646
2018
Q1 		$14.4M Buy
49,401
+36,432
+281% +$9.23M 0.04% 547
2017
Q4 		$2.43M Sell
12,969
-46,230
-78% -$8.63M 0.01% 829
2017
Q3 		$9.98M Sell
59,199
-1,683
-3% -$254K 0.03% 635
2017
Q2 		$8.72M Buy
60,882
+44,967
+283% +$6.04M 0.03% 659
2017
Q1 		$1.99M Sell
15,915
-178,735
-92% -$20.7M 0.01% 837
2016
Q4 		$21.9M Sell
194,650
-666,607
-77% -$77.2M 0.07% 397
2016
Q3 		$111M Buy
861,257
+31,916
+4% +$3.82M 0.34% 60
2016
Q2 		$90.6M Buy
829,341
+148,400
+22% +$14.8M 0.28% 79
2016
Q1 		$64.6M Buy
680,941
+256,394
+60% +$21.6M 0.2% 150
2015
Q4 		$38.3M Sell
424,547
-262,893
-38% -$22.3M 0.12% 275
2015
Q3 		$63.8M Sell
687,440
-109,540
-14% -$9.65M 0.19% 152
2015
Q2 		$52.4M Sell
796,980
-434,077
-35% -$28.8M 0.14% 235
2015
Q1 		$88.1M Buy
1,231,057
+418,377
+51% +$22.7M 0.22% 117
2014
Q4 		$30.9M Buy
+812,680
New +$25.6M 0.08% 360

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Lord, Abbett & Co's ABMD Position: Q2 2020 in Review

Lord, Abbett & Co sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 27,286 shares — an estimated $3.96M sold.

Lord, Abbett & Co first reported a position in ABMD in Q4 2014 and held it in 22 quarters. The position peaked at $111M in Q3 2016. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

  • Lord, Abbett & Co reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
  • Lord, Abbett & Co sold 27,286 Abiomed Inc shares in Q2 2020, an estimated $3.96M.
  • Lord, Abbett & Co first reported a position in Abiomed Inc in Q4 2014 and held it in 22 quarters.
  • Lord, Abbett & Co's Abiomed Inc position peaked at $111M in Q3 2016.
  • 460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Lord, Abbett & Co's 13F filing for Q2 2020, filed 14 Aug 2020.